Aicardi–Goutières syndrome (AGS) is a rare monogenic autoimmune disease that primarily
affects the brains of children patients. Its main clinical features include encephalatrophy …

Aicardi-Goutières syndrome (AGS) is a genetically determined early onset encephalopathy
characterized by cerebral calcification, leukodystrophy, and increased expression of …

Abstract Objective Aicardi‐Goutières syndrome (AGS) is an early‐onset encephalopathy
resembling congenital viral infection that is characterized by basal ganglia calcifications …

Aicardi–Goutières syndrome (AGS) is a rare disorder with in utero or postnatal onset of
encephalopathy and progressive neurological deterioration. The seven genetic subtypes of …

Aicardi–Goutières syndrome (AGS) is an early‐onset, autoimmune and genetically
heterogeneous disorder with severe neurologic injury. Molecular studies have established …

ABSTRACT Introduction: Aicardi-Goutières syndrome (AGS) is the prototype of the type I
interferonopathies, a new heterogeneous group of autoinflammatory disorders in which type …

The Aicardi–Goutières syndrome (AGS) was first described in 1984, and over the following
years was defined by the clinical and radiological features of an early onset, severe …

Abstract Background Aicardi-Goutières syndrome (AGS) is a genetic interferonopathy
characterized by early onset of severe neurological injury with intracranial calcifications …

Aicardi Goutières syndrome is a monogenic interferonopathy caused by abnormalities in the
intracellular nucleic acid sensing machinery (TREX1, RNASEH2A, RNASEH2B …

Aicardi-Goutières syndrome (AGS) is a genetically determined encephalopathy
demonstrating phenotypic overlap both with the sequelae of congenital infection and with …